Vineet Laboratories Ltd

Vineet Laborator Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Vineet Laboratories Ltd

₹ 50.8 0.40%
19 Apr 12:35 p.m.
vineetlabs.co.in BSE: 543298 NSE - BE : VINEETLAB
About

Incorporated in 2003, Vineet Laboratories Ltd is in designing, developing, manufacturing of API Intermediates and Bulk Drugs

Key Points

Product Profile:
a) API Intermediates:[1] Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine
b) Fine Chemicals and Reagents:[2] IPTG, PNPP, X-Gal, ATCA, Butyl Lithium, Furaldehyde, Butylnitrite, Aminouracil, etc.

Website BSE NSE - BE
  • Market Cap ₹ 46.8 Cr.
  • Current Price ₹ 50.8
  • High / Low ₹ 89.0 / 44.6
  • Stock P/E 17.6
  • Book Value ₹ 37.8
  • Dividend Yield 0.00 %
  • ROCE 8.69 %
  • ROE 3.74 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Promoter holding has decreased over last quarter: -1.11%
  • Promoter holding is low: 37.6%
  • Company has a low return on equity of 12.6% over last 3 years.
  • Working capital days have increased from 40.5 days to 65.8 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
243.48 57.67 39.55 38.36 55.59 48.82 39.51 66.76 57.20 37.52 43.37 32.65
235.33 54.94 37.74 35.72 49.52 44.90 43.52 64.81 51.39 37.26 39.20 33.29
Operating Profit 8.15 2.73 1.81 2.64 6.07 3.92 -4.01 1.95 5.81 0.26 4.17 -0.64
OPM % 3.35% 4.73% 4.58% 6.88% 10.92% 8.03% -10.15% 2.92% 10.16% 0.69% 9.61% -1.96%
0.39 0.03 0.16 -0.01 0.11 0.08 0.00 0.00 0.03 0.03 0.01 0.01
Interest 2.67 0.54 0.49 0.35 0.79 1.37 0.61 1.03 0.37 0.96 1.02 1.08
Depreciation 1.81 0.49 0.50 0.50 0.52 0.54 0.70 0.51 0.62 0.61 0.61 0.63
Profit before tax 4.06 1.73 0.98 1.78 4.87 2.09 -5.32 0.41 4.85 -1.28 2.55 -2.34
Tax % 56.16% 26.01% 25.51% 23.60% 32.44% 51.67% 11.84% -239.02% 26.80% 2.34% 4.71% 11.11%
1.78 1.28 0.72 1.36 3.28 1.01 -4.70 1.39 3.55 -1.25 2.42 -2.07
EPS in Rs 1.93 1.39 0.78 1.48 3.56 1.10 -5.10 1.51 3.85 -1.36 2.63 -2.25
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
0 243 191 212 171
0 235 178 205 161
Operating Profit -0 8 13 8 10
OPM % 3% 7% 4% 6%
0 0 0 0 0
Interest 0 3 2 3 3
Depreciation 0 2 2 2 2
Profit before tax -0 4 9 2 4
Tax % 0% 56% 29% 38%
-0 2 7 1 3
EPS in Rs -0.24 1.93 7.20 1.36 2.87
Dividend Payout % 0% 0% 14% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -19%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 403%
TTM: 170%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 5%
Return on Equity
10 Years: %
5 Years: %
3 Years: 13%
Last Year: 4%

Balance Sheet

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 0 9 9 9 9
Reserves -0 17 24 24 26
0 12 27 31 41
0 70 74 51 47
Total Liabilities 0 109 133 116 122
0 20 21 27 26
CWIP 0 0 0 0 0
Investments 0 0 0 0 0
0 89 112 89 96
Total Assets 0 109 133 116 122

Cash Flows

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023
0 27 8 -10
0 -8 -4 -7
0 19 12 0
Net Cash Flow 0 38 16 -16

Ratios

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 64 69 60
Inventory Days 73 109 98
Days Payable 114 161 74
Cash Conversion Cycle 23 17 84
Working Capital Days 28 28 66
ROCE % 34% 23% 9%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
35.96% 35.96% 35.96% 35.96% 35.96% 35.96% 35.96% 38.66% 38.66% 38.66% 37.55% 37.50%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.24% 0.00%
64.04% 64.04% 64.04% 64.04% 64.04% 64.04% 64.03% 61.35% 61.34% 61.34% 62.20% 62.50%
No. of Shareholders 7,3999,2169,1599,1649,5789,4369,5279,8219,3069,4699,5149,638

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports